According to the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 26 coronavirus vaccine options are being developed at 17 research institutions in Russia. One-dose vaccines are not only convenient, it also would be cheaper for the patients.
In testimony before the U.S. Congress on July 31, Anthony Fauci, the United States' top infectious-diseases official, expressed concern about reported COVID-19 vaccines being developed in Russian Federation and China.
Immunogenicity or the amount of immune response generated by a vaccine is at the crux of this research.
The approval for these trials had come late night on Sunday as DCGI Dr V G Somani gave approvals after evaluating the recommendations of the Subject Expert Committee on COVID-19, the report said.
SII which has partnered with AstraZeneca for manufacturing the Oxford vaccine candidate for COVID-19 had submitted its first application to the DCGI on Friday seeking permission for conducting phase 2 and 3 trials of Covishield.
Each subject will be administered two doses in a gap of four weeks (first dose on day one and second dose on day 29) following which the safety and efficacy will be assessed.
Microsoft halts bid to buy TikTok's U.S. operations
TikTok has long argued it does not share worldwide user data with Beijing and maintains it respects user privacy. Meanwhile, news came that Microsoft has made a decision to buy the company's TikTok US operation.
Russian Federation is preparing to start a mass vaccination campaign against the coronavirus in October, the country's government has claimed.
Last month, Russian Federation was accused by officials in the U.S., Canada and Britain of trying to hack and steal coronavirus vaccine data.
But right now it's not entirely clear how much of the coronavirus vaccine that Serum will mass-produce will be kept by India or who will fund its production, leaving the Poonawallas to navigate a torrent of cross-pressures, political, financial, external and domestic.
"We expect to start production already in November this year", Maksyutov told Rossiya-1 TV's Vesti program, according to TASS.
Another vaccine, developed by Siberia-based Vektor lab, is now undergoing clinical trials and two more will begin human testing within the next two months, Health Minister Mikhail Murashko said on Saturday. The EU wants to ink deals with six drugmakers for their coronavirus vaccine for 450 million citizens.